查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1616777

基因檢測市場機會、成長動力、產業趨勢分析與預測 2024 - 2032

Genetic Testing Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 136 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023 年全球基因檢測市場價值為186 億美元，預計2024 年至2032 年間將以12.3% 的複合年成長率強勁成長。的生物資訊學工具，顯著提高了基因檢測的準確性、效率和可負擔性。此外，基因檢測與數位健康平台和電子健康記錄的整合使基因資訊更容易取得和操作，增強了其在臨床和消費者健康環境中的效用。消費者發起的基因檢測服務和產品的不斷增加也促進了市場的成長。這些服務為個人提供了對其遺傳健康風險的個人化見解，使遺傳訊息更加方便用戶使用，並得到個人化健康報告和遺傳諮詢等工具的支持。

此外，旨在加速基因組學領域技術創新的持續研究經費預計將推動基因檢測產業的持續擴張。就產品和服務而言，市場分為試劑盒和試劑以及軟體和服務。 2023 年，試劑盒和試劑細分市場佔據主導地位，收入達 121 億美元。特別是次世代定序(NGS) 試劑盒的需求量很大，因為它們能夠對整個基因組或特定區域進行定序，從而促進全面的遺傳分析。提供試劑：樣本庫製備、定序和資料分析。按測試類型分類時，市場包括預測測試、攜帶者測試、產前和新生兒測試、診斷測試、藥物基因組學、營養基因組學等。到2023 年，產前和新生兒檢測領域以39.6% 的佔有率引領市場。發現遺傳性疾病沒有與侵入性手術相關的風險。從地區來看，北美擁有最大的市場佔有率，到2023 年將佔46.3%。對基因的高度認知疾病及其治療方案也推動了北美對基因檢測服務和產品的需求，使其成為全球市場成長軌蹟的關鍵參與者。

市場範圍
開始年份 2023年
預測年份 2024-2032
起始值 186 億美元
預測值 523 億美元
複合年成長率 12.3%

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 技術進步和新測試的可用性
      • 基因檢測在腫瘤學和遺傳疾病的應用日益廣泛
      • 消費者對個人化醫療的偏好不斷增加
      • 對直接面對消費者的基因檢測的需求不斷成長
    • 產業陷阱與挑戰
      • 基因檢測費用高
      • 發展中經濟體和已開發經濟體缺乏經驗豐富的專業人員和先進的基礎設施
  • 成長潛力分析
  • 監管環境
  • 技術景觀
  • 報銷場景
  • 波特的分析
  • PESTEL分析

第 4 章：競爭格局

  • 介紹
  • 公司市佔率分析
  • 公司矩陣分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 戰略儀錶板

第 5 章：市場估計與預測：按產品和服務分類，2021 - 2032 年

  • 主要趨勢
  • 試劑盒和試劑
  • 軟體與服務

第 6 章：市場估計與預測：按測試類型，2021 - 2032

  • 主要趨勢
  • 預測測試
  • 營運商測試
  • 產前和新生兒檢測
  • 診斷測試
  • 藥物基因組測試
  • 營養基因體學
  • 其他測試類型

第 7 章：市場估計與預測：按應用分類，2021 - 2032

  • 主要趨勢
  • 癌症治療
  • 移植組織分型
  • 法醫身分測試
  • 血統測試
  • 親子鑑定
  • 其他應用

第 8 章：市場估計與預測：按技術分類，2021 - 2032 年

  • 主要趨勢
  • 聚合酶鍊式反應
  • DNA定序
    • 桑格定序
    • 下一代定序
  • 細胞遺傳學檢測
    • 染色體分析（核型分析）
    • 螢光原位雜合技術（FISH）
  • 微陣列
  • 基因表現譜

第 9 章：市場估計與預測：依最終用途，2021 - 2032 年

  • 主要趨勢
  • 醫院和診所
  • 診斷實驗室
  • 法醫實驗室
  • 其他最終用戶

第 10 章：市場估計與預測：按地區分類，2021 - 2032 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 11 章：公司簡介

  • 23 and ME, Inc.
  • Abbott Laboratories
  • Ambry genetics
  • Ancestry DNA
  • bioMerieux SA
  • BGI Genomics
  • Illumina, Inc.
  • Invitae Corporation
  • Luminex Corporation
  • Myriad Genetics, Inc.
  • Natera, Inc.
  • QIAGEN NV
  • Quest Diagnostics
  • Siemens Healthineers AG
簡介目錄
Product Code: 2490

The Global Genetic Testing Market was valued at USD 18.6 billion in 2023 and is projected to grow at a robust CAGR of 12.3% between 2024 and 2032. This growth is driven by advancements in genomics, such as high-throughput sequencing technologies and enhanced bioinformatics tools, which have significantly improved the accuracy, efficiency, and affordability of genetic testing. Additionally, the integration of genetic testing with digital health platforms and electronic health records has made genetic information more accessible and actionable, enhancing its utility in both clinical and consumer health settings. The increasing availability of consumer-initiated genetic testing services and products is also contributing to market growth. These services provide individuals with personalized insights into their genetic health risks, making genetic information more user-friendly and supported by tools like personalized health reports and access to genetic counseling.

Further, ongoing research funding aimed at accelerating technological innovation in the genomics sector is expected to drive continued expansion in the genetic testing industry. In terms of products and services, the market is segmented into kits & reagents and software & services. The kits & reagents segment dominated the market in 2023, generating USD 12.1 billion in revenue. Next-generation sequencing (NGS) kits, in particular, are in high demand due to their ability to sequence entire genomes or specific regions, facilitating comprehensive genetic analysis.These kits are critical for both clinical diagnostics and research, offering reagents for processes such as library preparation, sequencing, and data analysis. When classified by test type, the market includes predictive testing, carrier testing, prenatal & newborn testing, diagnostic testing, pharmacogenomics, nutrigenomics, and others. The prenatal and newborn testing segment led the market with a 39.6% share in 2023. This segment's dominance is driven by the growing adoption of advanced screening methods, such as non-invasive prenatal testing (NIPT), which allow for early detection of genetic disorders without the risks associated with invasive procedures. Regionally, North America held the largest market share, accounting for 46.3% in 2023. The region's dominance is supported by a strong presence of key market players, advanced healthcare infrastructure, and leading research institutions focused on genetic research.High levels of awareness about genetic disorders and their treatment options also drive the demand for genetic testing services and products in North America, positioning it as a key player in the global market growth trajectory.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$18.6 Billion
Forecast Value$52.3 Billion
CAGR12.3%

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Technological advancement and availability of new tests
      • 3.2.1.2 Growing application of genetic testing in oncology and genetic diseases
      • 3.2.1.3 Increasing consumer preference for personalized medicine
      • 3.2.1.4 Growing demand for direct-to-consumer genetic testing
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of genetic testing
      • 3.2.2.2 Dearth of experienced professionals and advanced infrastructure in developing and developed economies
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technology landscape
  • 3.6 Reimbursement scenario
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Products & Services, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Kits & reagents
  • 5.3 Software & services

Chapter 6 Market Estimates and Forecast, By Test Type, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Predictive testing
  • 6.3 Carrier testing
  • 6.4 Prenatal and newborn testing
  • 6.5 Diagnostic testing
  • 6.6 Pharmacogenomic testing
  • 6.7 Nutrigenomics
  • 6.8 Other test types

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Cancer treatment
  • 7.3 Tissue typing for transplantation
  • 7.4 Forensic identity testing
  • 7.5 Ancestry testing
  • 7.6 Paternity testing
  • 7.7 Other applications

Chapter 8 Market Estimates and Forecast, By Techniques, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Polymerase chain reaction
  • 8.3 DNA sequencing
    • 8.3.1 Sanger sequencing
    • 8.3.2 Next generation sequencing
  • 8.4 Cytogenetic testing
    • 8.4.1 Chromosome analysis (karyotyping)
    • 8.4.2 Fluorescence in situ hybridization (FISH)
  • 8.5 Microarrays
  • 8.6 Gene expression profiling

Chapter 9 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 Hospitals & clinics
  • 9.3 Diagnostic laboratories
  • 9.4 Forensic laboratories
  • 9.5 Other end-users

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 10.1 Key trends
  • 10.2 North America
    • 10.2.1 U.S.
    • 10.2.2 Canada
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 France
    • 10.3.4 Spain
    • 10.3.5 Italy
    • 10.3.6 Netherlands
    • 10.3.7 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 South Korea
    • 10.4.6 Rest of Asia Pacific
  • 10.5 Latin America
    • 10.5.1 Brazil
    • 10.5.2 Mexico
    • 10.5.3 Rest of Latin America
  • 10.6 Middle East and Africa
    • 10.6.1 South Africa
    • 10.6.2 Saudi Arabia
    • 10.6.3 UAE
    • 10.6.4 Rest of Middle East and Africa

Chapter 11 Company Profiles

  • 11.1 23 and ME, Inc.
  • 11.2 Abbott Laboratories
  • 11.3 Ambry genetics
  • 11.4 Ancestry DNA
  • 11.5 bioMerieux SA
  • 11.6 BGI Genomics
  • 11.7 Illumina, Inc.
  • 11.8 Invitae Corporation
  • 11.9 Luminex Corporation
  • 11.10 Myriad Genetics, Inc.
  • 11.11 Natera, Inc.
  • 11.12 QIAGEN N.V.
  • 11.13 Quest Diagnostics
  • 11.14 Siemens Healthineers AG